Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 423 participants.
Also called NCT06935591
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 423 participants
- Sponsor
- Vektor Medical
- Registry
-
NCT06935591
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT06935591. Randomized; no masking; primary purpose treatment. Start 2025-06-27 (actual); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
- Acronym
- IMPRoVED-AF
- Condition
- Atrial Fibrillation (AF)
- Intervention (Procedure)
- Pulmonary Vein Isolation
- Intervention (Device)
- vMap® + Pulmonary Vein Isolation
- Lead sponsor
- Vektor Medical
- Collaborator
- Veranex Switzerland SA
- Collaborator
- Veranex
Record details
- Record id
cardio:ct-nct06935591- Content hash
ea9161d45f79e34db5fe370d6168991067c57fd51dccf892b3c3a478cad25e77